Skip to main content
Premium Trial:

Request an Annual Quote

PrediLife Partners With Institut Curie on Breast Cancer Risk Test

NEW YORK (GenomeWeb) — PrediLife said today that it has signed on the Institut Curie to perform the genetic analysis portion of its MammoRisk breast cancer risk assay.

MammoRisk — used in conjunction with mammograms — is designed to determine breast cancer risk using a patient's age, breast density, family history, and breast biopsy history, as well as a polygenic score based on the analysis of disease-linked genetic variations from a saliva sample.

Under the terms of their deal, the Institut Curie will perform MammoRisk genetic analyses, focusing on roughly 100 polymorphisms associated with increased breast cancer risk. The partners also intend to work together on future breast cancer-related research projects, Villejuif, France-based PrediLife said.

Additional terms were not disclosed.

"The collaboration underscores the ability of the Institut Curie's genomics platform to provide academic and industrial partners such as PrediLife with technological tools for high-throughput genomic analysis," David Gentien, head of the institute's genomics platform, said in a statement.

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.